Interestingly, these data demonstrated that CRISPR KO of FBXO9 led to a CERES project score of ~−0.2; this trend is similar to BRCA1 and BRCA2, which are well-known tumor suppressors associated with DNA damage repair. This evidence concerns the gene BRCA2 and neoplasm.